Perceived Effectiveness of Medical Cannabis Among Adults with Chronic Pain: Findings from Interview Data in a Three-Month Pilot Study.
Perceived Effectiveness of Medical Cannabis Among Adults with Chronic Pain: Findings from Interview Data in a Three-Month Pilot Study.
复制标题
DOI：
10.26828/cannabis/2023/000149
复制
发表时间：
2023
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
患者报告的结果对于评估医用大麻作为慢性疼痛替代疗法的有效性至关重要。这项研究调查了新开始使用医用大麻的中老年人对医用大麻治疗慢性疼痛的感知有效性。对一项为期三个月的试点研究参与者的采访数据进行了分析，以评估医用大麻对慢性疼痛和相关结果的感知有效性。访谈是在大约使用一个月后进行的，并使用 RADaR（严格和加速数据缩减）技术对回复进行了分析。 51 名因慢性疼痛而开始使用医用大麻的成年人接受了采访（24 名女性，27 名男性，平均年龄 54.4 岁，SD = 12.0），其中大多数（n = 41）被确定为非西班牙裔白人，其次是非西班牙裔黑人（n = 7），多种族（2），西班牙裔白人（1）。大多数研究参与者 (62.7%) 报告 MC 总体有效。常见的好处包括减轻疼痛强度、焦虑以及对疼痛和精神药物的依赖。据报道，身体机能、睡眠质量和情绪都有所改善。常见的挑战包括难以找到合适的产品或剂量、出现副作用，例如“不受欢迎的高感”、“胃部问题”以及产品可治疗的“疼痛阈值”有限。研究结果表明，大多数参与者认为医用大麻对慢性疼痛管理总体有效。参与者报告身体和精神功能得到改善，疼痛和精神药物的使用减少。未来的研究需要系统地评估副作用、剂量和消费方式，以进一步评估成人开始使用医用大麻的结果。
Patient-reported outcomes are critical to evaluate the effectiveness of medical cannabis as an alternative treatment for chronic pain. This study examined the perceived effectiveness of medical cannabis for chronic pain management among middle-aged and older adults newly initiating medical cannabis. Interview data from participants in a three-month pilot study were analyzed to assess the perceived effectiveness of medical cannabis on chronic pain and related outcomes. The interview was conducted after approximately one month of usage and responses were analyzed using the RADaR (Rigorous and Accelerated Data Reduction) technique. 51 adults initiating medical cannabis for chronic pain were interviewed (24 women, 27 men, mean age 54.4, SD = 12.0), with the majority (n=41) identifying as Non-Hispanic White followed by Non-Hispanic Black (n=7), Multi-racial (2), Hispanic White (1). Most study participants (62.7%) reported MC being overall effective. Common benefits included reduced pain intensity, anxiety, and dependency on pain and psychiatric medications. Improvements in physical functioning, sleep quality, and mood were reported. Common challenges included difficulty finding a suitable product or dose, experiencing side effects such as ‘undesired high’, ‘stomach issues’, and a limited ‘threshold of pain’ treatable by the product. Findings suggest most participants perceived medical cannabis to be overall effective for chronic pain management. Participants reported improved physical and mental functioning and reduced use of pain and psychiatric medications. Future research systematically assessing side effects, dosage and mode of consumption is needed to further evaluate the outcomes among adults initiating medical cannabis.